We’ve seen investments in software, energy, and life sciences companies in the last week, plus the closing of a big investment fund for a healthcare-focused venture firm.
—Extreme Reach, a maker of software for delivering and tracking video advertisements across multiple platforms, wrapped up a $9 million Series B funding round. Village Ventures led the round for Needham, MA-based Extreme Reach, which was made up of $7 million in equity and $2 million in term debt, and also included backing from Greycroft Partners and Long River Ventures.
—Beverly, MA-based SiOnyx, a company developing black silicon as a more sensitive detector for imaging systems, pulled in $6.3 million of an equity round of financing that could be worth as much as $12 million. In 2007, Harris & Harris, Polaris Venture Partners, and RedShift Ventures invested $11 million in SiOnyx, a Harvard University spinout.
—Content management software company Nuxeo added another $3.3 million to its Series A financing, bringing the round’s total to $5.9 million. OTC Asset Management led the investment for Paris-based Nuxeo, which has U.S. operations in Burlington, MA.
—Boston-Power, a Westborough, MA-based maker of lithium-ion batteries and energy storage technologies, said it has reeled in $60 million in Series E growth equity funding. Existing Boston-Power investors Foundation Asset Management and Oak Investment Partners co-led the financing, which included backing from return investors Venrock and Gabriel Venture Partners. The newest cash brings the startup’s funding total to $185 million and will go toward battery production, international expansion, and the company’s sales, marketing, operations, and engineering teams.
—Waltham, MA-based Blu Homes, a green building company, raised $6.9 million in equity-based funding, an SEC filing revealed. The company originally announced the financing in May, and said the money will go to new product development, sales, marketing, and research.
—The New York Times reported that MIT spinout Lantos Technologies, a Cambridge, MA-based hearing and audio company developing 3D imaging technology for the ear canal, will announce a $1.5 million financing. (We haven’t seen any further announcements from the company on this yet.)
—Cambridge’s BIND Biosciences, a developer of nanoparticle-based drugs, closed $12.4 million in Series C funding, to put toward a Phase 1 clinical trial of its treatment for solid tumors. Swiss venture firm Endeavour Vision, which has Johnson & Johnson (NYSE: JNJ) veteran Eric Milledge on staff, joined in on BIND’s third round of funding. The Series C money also came from existing backers such as Arch Venture Partners, DHK Investments, Flagship Ventures, NanoDimension, and Polaris Venture Partners.
—Acton, MA-based Everyday Solutions, a maker of GPS-based software and hardware for monitoring school buses, pulled in a $2.8 million equity round. The company is backed by Ascent Venture Partners, Flagship Ventures, and Fontinalis Partners.
—Boston-based venture firm SV Life Sciences reported it had closed its latest fund at $523 million, the second-largest healthcare fund raised this year, after OrbiMed Advisors’ $550 million fund. The SV Life Sciences Fund V will target companies in the therapeutics, medical devices, diagnostics, healthcare services, and health IT spaces, and will make investments ranging from $5 million to $35 million.